Dublin, Ohio-based Cardinal Health, Inc. (CAH) manufactures and distributes pharmaceuticals, medical & laboratory products, and performance & data solutions for healthcare facilities. With a market cap of $30.8 billion, Cardinal operates in over 30 countries and employs over 48,000 people across the globe.
While Cardinal Health has lagged behind the broader market over the past year by a small margin, it has significantly outpaced the market in 2025. CAH stock has soared 20.5% over the past 52 weeks and 7.7% in 2025, compared to the S&P 500 Index’s ($SPX) 20.6% gains over the past year and 2.5% surge on a YTD basis.
